How did the Polynovo share price respond last time the company reported?

Polynovo shares will be on watch tomorrow as the company reports its earnings. Let's look back to see what happened last time.

| More on:
Two happy scientists analysing test results in a lab

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Polynovo Ltd (ASX: PNV) share price is having a pretty pleasing day of trade this Thursday. At present, Polynovo shares are up an encouraging 2% at $2.04 each.

That compares well against the S&P/ASX 200 Index (ASX: XJO), which is also in the green, but by 0.76% at about 7,051 points. So a market-beating kind of day for Polynovo shares.

But today is just a warm-up act. Because all eyes will be on this ASX healthcare company tomorrow when it reports its full-year earnings for the 2022 financial year.

Now, we obviously can't predict what is going to happen to Polynovo shares tomorrow from where we stand today. They could go up, go down, or stay flat. But what we can do is take a look at what happened to the Polynovo share price the last time this company reported earnings.

What happened to the Polynovo share price last earnings season?

So Polynovo's last reporting date with ASX investors was back on 25 February of this year. That was when the company dropped its half-year results for FY2022, which covered the six months to 31 December 2021.

As we covered at the time, the company reported a 41.9% surge in revenue to $18.15 million. That led to Polynovo announcing an underlying profit after tax of $1.618 million. That was up from the previous year's loss of $3.57 million.

However, the company still reported a net loss after tax of $1.7 million when non-cash items were excluded.

So how did Polynovo shares react to these earnings? Well, it was an interesting tale.

Upon the release of this report on Friday 25 February, the Polynovo share price ended the trading day with a loss of 3.77%. The following Monday saw the company lose another 1.96%, but the next day the company gained an impressive 10%.

Now this experience in no way tells us what exactly will happen with the Polynovo share price tomorrow. If the results are above the market's expectations, the shares will, in all likelihood, go up. If they are below expectations, the shares might fall. But it's still an interesting insight into what can happen during earnings season.

At the current Polynovo share price, this ASX 200 healthcare share has a market capitalisation of $1.35 billion.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Has the Pro Medicus share price risen too high too quickly?

Pro Medicus shares have rocketed 173% since this time last year.

Read more »